Cutting edge issues in autoimmune hepatitis

Clinical Reviews in Allergy and Immunology

Volumn 42, Issue 3, 2012, Pages 309-321

  Vergani, Diego ^a   Mieli Vergani, Giorgina ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Autoantibody; Autoimmune hepatitis; Cellular immunity; Humoral immunity; Immune regulation; Liver

Indexed keywords

ANTINUCLEAR ANTIBODY; MICROSOME ANTIBODY; SMOOTH MUSCLE ANTIBODY;

ARTICLE; AUTOIMMUNE HEPATITIS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL FEATURE; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HUMORAL IMMUNITY; LYMPHOCYTE FUNCTION; MONOCYTE; NONHUMAN; PATHOGENESIS;

ANIMALS; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MOLECULAR MIMICRY; T-LYMPHOCYTES, REGULATORY;

EID: 84865266299     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-010-8236-9     Document Type: Article

References (89)

1. Krawitt E (2006) Autoimmune hepatitis. N Engl J Med 354(1):54-66
2. Vergani D, Mieli-Vergani G (2007) Autoimmune hepatitis. Textbook of hepatology: From basic science to clinical practice, 3rd edn. Blackwell Publishing, UK, pp 1089-1101
3. Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, et al. (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51(6):2193-2213
4. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H (1998) Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 33(1):99-103
5. Manns MP, Luttig B, Obermayer-Straub P (1998) Autoimmune Hepatitis. In: Rose NR, Mackay IR (eds) The autoimmune diseases, 3rd edn. Academic Press, New York, pp 511-25
6. Primo J, Merino C, Fernandez J, Moles JR, Llorca P, Hinojosa J (2004) Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto (Spain). Gastroenterol Hepatol 27(4):239-243
7. Ma Y, Okamoto M, Thomas MG, Bogdanos DP, Lopes AR, Portmann B, et al. (2002) Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 35:658-664
8. Czaja AJ, Donaldson PT, Lohse AW (2002) Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol 97(2):413-419
9. Crapper RM, Bhathal PS, Mackay IR, Frazer IH (1986) 'Acute' autoimmune hepatitis. Digestion 34(3):216-225
10. Amontree JS, Stuart TD, Bredfeldt JE (1989) Autoimmune chronic active hepatitis masquerading as acute hepatitis. J Clin Gastroenterol 11(3):303-307
11. Gregorio GV, Portman B, Reid F, Donaldson PT, Doherty DG, McCartney M (1997) Autoimmune hepatitis in childhood: A 20-year experience. Hepatology 25:541-547
12. Reuben A (2003) A sheep in wolf's clothing. Hepatology 38 (6):1596-1601
13. Simmonds MJ, Gough SC (2004) Genetic insights into disease mechanisms of autoimmunity. Br Med Bull 71:93-113
14. Liston A, Lesage S, Gray DH, Boyd RL, Goodnow CC (2005) Genetic lesions in T-cell tolerance and thresholds for autoimmunity. Immunol Rev 204:87-101
15. Ahonen P, Myllarniemi S, Sipila I, Perheentupa J (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322 (26):1829-1836
16. Manns MP, Woynarowski M, Kreisel W, Lurie Y, Rust C, Zuckerman E, et al. (2010) Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis. Gastroenterology 139(4):1198-1206
17. Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, et al. (2001) Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study. Hepatology 33(3):544-553
18. Johnson PJ (1993) Meeting report: International autoimmune hepatitis group. Hepatology 18(4):998-1005
19. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. (1999) International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatology 31:929-938
20. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48(1):169-176
21. Bogdanos DP, Invernizzi P, Mackay IR, Vergani D (2008) Autoimmune liver serology: Current diagnostic and clinical challenges. World J Gastroenterol 14(21):3374-3387
22. Duchini A, McHutchison JG, Pockros PJ (2000) LKM-positive autoimmune hepatitis in the western United States: A case series. Am J Gastroenterol 95(11):3238-3241
23. Vergani D, Alvarez F, Bianchi FB, Cancado EL, Mackay IR, Manns MP, et al. (2004) Liver autoimmune serology: A consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group. J Hepatol 41(4):677-683
24. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, et al. (1997) Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 40(9):1601-1611
25. Bottazzo GF, Florin-Christensen A, Fairfax A, Swana G, Doniach D, Groeschel-Stewart U (1976) Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol 29 (5):403-410
26. Granito A, Muratori L, Muratori P, Pappas G, Guidi M, Cassani F, et al. (2006) Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol 59(3):280-284
27. Rizzetto M, Swana G, Doniach D (1973) Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol 15(3):331-344
28. Montano-Loza AJ, Carpenter HA, Czaja AJ (2008) Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis. J Clin Gastroenterol 42 (9):1047-1053
29. O'Brien C, Joshi S, Feld JJ, Guindi M, Dienes HP, Heathcote EJ (2008) Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 48(2):550-556
30. Martini E, Abuaf N, Cavalli F, Durand V, Johanet C, Homberg JC (1988) Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology 8 (6):1662-1666
31. Muratori L, Cataleta M, Muratori P, Manotti P, Lenzi M, Cassani F (1995) Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: Comparison of different techniques. J Immunol Methods 187(2):259-264
32. Lapierre P, Hajoui O, Homberg JC, Alvarez F (1999) Formimino-transferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis. Gastroenterology 116(3):643-649
33. Manns M, Gerken G, Kyriatsoulis A, Staritz M, Buschenfelde KH Meyer zum (1987) Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1:292-294
34. Stechemesser E, Strienz J, Berg PA (1987) Serological definition of new subgroup of patients with autoimmune chronic active hepatitis. Lancet 1(8534):683
35. Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Buschenfelde KH, et al. (2000) Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis [see comments]. Lancet 355(9214):1510-1515
36. Costa M, Rodriguez-Sanchez JL, Czaja AJ, Gelpi C (2000) Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis. Clin Exp Immunol 121(2):364-374
37. Bogdanos DP, Mieli-Vergani G, Vergani D (2009) Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis 29 (3):241-253
38. Palioura S, Sherrer RL, Steitz TA, Soll D, Simonovic M (2009) The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation. Science 325(5938):321-325
39. Donaldson P (2002) Genetics in autoimmune hepatitis. Semin Liver Dis 22(4):353-364
40. Donaldson PT (2004) Genetics of liver disease: Immunogenetics and disease pathogenesis. Gut 53(4):599-608
41. Czaja AJ, Donaldson PT (2000) Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev 174:250-259
42. Fainboim L, Marcos Y, Pando M, Cappuchio M, Reyes GB, Galoppo C, et al. (1994) Chronic active autoimmune hepatitis in children: Strong association with a particular HLA-DR6 (DRB11301) haplotype. Hum Immunol 41:146-150
43. Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, et al. (2006) Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 130(3):868-882
44. Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D (1992) Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Arch Dis Child 67(12):1447-1453
45. Lobo-Yeo A, Senaldi G, Portmann B, Mowat AP, Mieli-Vergani G, Vergani D (1990) Class I and class II major histocompatibility complex antigen expression on hepatocytes: A study in children with liver disease. Hepatology 12(2):224-232
46. Senaldi G, Lobo-Yeo A, Mowat AP, Mieli-Vergani G, Vergani D (1991) Class I and class II major histocompatibility complex antigens on hepatocytes: Importance of the method of detection and expression in histologically normal and diseased livers. J Clin Pathol 44(2):107-114
47. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8(6):639-646
48. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24(2):179-189
49. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8(9):950-957
50. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8(9):942-949
51. Gerosa F, Baldani-Guerra B, Lyakh LA, Batoni G, Esin S, Winkler-Pickett RT, et al. (2008) Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J Exp Med 205(6):1447-1461
52. Nouri-Aria KT, Hegarty JE, Alexander GJ, Eddleston AL, Williams R (1982) Effect of corticosteroids on suppressor cell activity in "autoimmune" and viral chronic active hepatitis. N Engl J Med 307(21):1301-1304
53. Vento S, Hegarty JE, Bottazzo G, Macchia E, Williams R, Eddleston AL (1984) Antigen specific suppressor cell function in autoimmune chronic active hepatitis. Lancet 1(8388):1200-1204
54. Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D (2004) Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41(1):31-37
55. Longhi MS, Ma Y, Mitry RR, Bogdanos DP, Heneghan M, Cheeseman P, et al. (2005) Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 25(1):63-71
56. Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, Vergani D, et al. (2006) Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 176(7):4484-4491
57. Longhi MS, Meda F, Wang P, Samyn M, Mieli-Vergani G, Vergani D, et al. (2008) Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis. Hepatology 47 (2):581-591
58. Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A, et al. (2010) A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 52(3):999-1007
59. Longhi MS, Hussain MJ, Kwok WW, Mieli-Vergani G, Ma Y, Vergani D (2011) Auto-antigen-specific regulatory T-cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis. Hepatology (in press)
60. Sakaguchi S (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531-562
61. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4(4):330-336
62. Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6(4):345-352
63. Ruprecht CR, Gattorno M, Ferlito F, Gregorio A, Martini A, Lanzavecchia A, et al. (2005) Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201(11):1793-1803
64. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203(7):1693-1700
65. Longhi MS, Mitry RR, Samyn M, Scalori A, Hussain MJ, Quaglia A, et al. (2009) Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells. Hepatology 50(1):130-142
66. Akbar AN, Taams LS, Salmon M, Vukmanovic-Stejic M (2003) The peripheral generation of CD4+ CD25+ regulatory T cells. Immunology 109(3):319-325
67. Gueguen M, Meunier-Rotival M, Bernard O, Alvarez F (1988) Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily. J Exp Med 168(2):801-806
68. Kerkar N, Choudhuri K, Ma Y, Mahmoud A, Bogdanos DP, Muratori L, et al. (2003) Cytochrome P4502D6(193-212): A new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 170(3):1481-1489
69. Longhi MS, Hussain MJ, Bogdanos DP, Quaglia A, Mieli-Vergani G, Ma Y, et al. (2007) Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology 46(2):472-484
70. Vergani GM, Vergani D, Jenkins PJ, Portmann B, Mowat AP, Eddleston AL, et al. (1979) Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Clin Exp Immunol 38(1):16-21
71. Vergani D, Mieli-Vergani G, Mondelli M, Portmann B, Eddleston AL (1987) Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage. Liver 7(6):307-315
72. Jensen DM, McFarlane IG, Portmann BS, Eddleston AL, Williams R (1978) Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med 299(1):1-7
73. McFarlane BM, McSorley CG, Vergani D, McFarlane IG, Williams R (1986) Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol 3(2):196-205
74. Muratori L, Parola M, Ripalti A, Robino G, Muratori P, Bellomo G, et al. (2000) Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 46(4):553-561
75. Ma Y, Thomas MG, Okamoto M, Bogdanos DP, Nagl S, Kerkar N, et al. (2002) Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol 169(1):277-285
76. Wen L, Peakman M, Lobo-Yeo A, McFarlane BM, Mowat AP, Mieli-Vergani G, et al. (1990) T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis. Lancet 336(8730):1527-1530
77. Wen L, Ma Y, Bogdanos DP, Wong FS, Demaine A, Mieli-Vergani G, et al. (2001) Pediatric autoimmune liver diseases the molecular basis of humoral and cellular immunity. Curr Mol Med 1(3):379-389
78. Lohr H, Manns M, Kyriatsoulis A, Lohse AW, Trautwein C, Meyer zum Buschenfelde KH, et al. (1991) Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis. Clin Exp Immunol 84 (2):297-302
79. Lohr H, Treichel U, Poralla T, Manns M, Meyer zum Buschenfelde KH (1992) Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro. Clin Exp Immunol 88(1):45-49
80. Manns MP, Griffin KJ, Sullivan KF, Johnson EF (1991) LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 88(4):1370-1378
81. Gregorio GV, Choudhuri K, Ma Y, Vegnente A, Mieli-Vergani G, Vergani D (1999) Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. J Immunol 162(3):1802-1810
82. Gregorio GV, Choudhuri K, Ma Y, Pensati P, Iorio R, Grant P, et al. (2003) Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol 133 (3):404-13
83. Bortolotti F, Vajro P, Balli F, Giacchino R, Crivellaro C, Barbera C, et al. (1996) Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol 25(5):614-620
84. Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L, et al. (1999) Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: A nested case-control study of the Dionysos cohort. Gut 45(3):435-441
85. Bogdanos DP, Choudhuri K, Vergani D (2001) Molecular mimicry and autoimmune liver disease: Virtuous intentions, malign consequences. Liver 21(4):225-32
86. Mackie FD, Peakman M, Yun M, Sallie R, Smith H, Davies ET, et al. (1994) Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus. Gastroenterology 106(6):1672-1675
87. Lapierre P, Djilali-Saiah I, Vitozzi S, Alvarez F (2004) A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens. Hepatology 39(4):1066-1074
88. Lapierre P, Beland K, Martin C, Alvarez F Jr, Alvarez F (2010) Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis. Hepatology 51 (5):1789-1798
89. Holdener M, Hintermann E, Bayer M, Rhode A, Rodrigo E, Hintereder G, et al. (2008) Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med 205(6):1409-1422